Company profile: SynAgile
1.1 - Company Overview
Company description
- Provider of DopaFuse, a continuous oral infusion therapy designed to stabilize L-DOPA levels for Parkinsonβs disease patients.
Products and services
- DopaFuse: A continuous oral infusion therapy engineered to stabilize L-DOPA levels in the body for Parkinsonβs disease patients through sustained, orally delivered administration
- DopaFuse Oral Infusion: Delivers continuous oral infusion to stabilize L-DOPA levels for Parkinsonβs disease patients via ongoing administration to the body
- DopaFuse Parkinsonβs Therapy: Offers continuous oral infusion therapy intended to stabilize L-DOPA levels for Parkinsonβs disease patients using extended oral administration
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to SynAgile
ADC Bio
HQ: United Kingdom
Website
- Description: Provider of process technology for antibody drug conjugates (ADCs), helping drug developers address conjugation challenges in testing and production of ADC-based anti-cancer drugs, enabling faster, simpler and lower-cost development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full ADC Bio company profile β
Pressure BioSciences
HQ: United States
Website
- Description: Provider of proprietary laboratory instrumentation and consumables: Pressure Cycling Technology (PCT) for controlled biomolecular interactions (cell lysis, biomolecule extraction) in biomarker discovery, drug design and forensics; BaroFold for high-pressure protein disaggregation/refolding to remove aggregates and enhance product safety and efficacy; and Ultra Shear Technology (UST) to make stable nanoemulsions, improving solubility and stability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Pressure BioSciences company profile β
Zeptosens
HQ: Switzerland
Website
- Description: Provider of ultra-sensitive microarray platforms for quantitative proteomic investigations, delivering sensitive, quantitative protein profiling and signaling pathway analysis via reverse protein arrays. Products include ZeptoREADER, a microarray reader for planar waveguide technology, and ZeptoMARK.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Zeptosens company profile β
Teneobio
HQ: United States
Website
- Description: Provider of human heavy chain antibody discovery and development, with pre-clinical and clinical programs for multiple myeloma, prostate cancer, and immune disorders. Its antibody discovery engine is based on UniRatβ’.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Teneobio company profile β
Primerdesign
HQ: United Kingdom
Website
- Description: Provider of real-time PCR solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Primerdesign company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for SynAgile
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SynAgile
2.2 - Growth funds investing in similar companies to SynAgile
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for SynAgile
4.2 - Public trading comparable groups for SynAgile
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β